Added to YB: 2024-04-24
Pitch date: 2024-04-24
FUSN [bullish]
Fusion Pharmaceuticals Inc.
+0.84%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Fusion Pharmaceuticals Inc. operates as a clinical-stage biopharmaceutical company developing targeted radiopharmaceutical therapies for the treatment of cancer.
Market Cap
$1.8B
Pitch Price
$21.37
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-15.11
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
FUSION PHARMACEUTI INC FUSN
A summary for this pitch has not been created yet.
Read full article (0 min)